Bill

Bill > S657


US S657

US S657
A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.


summary

Introduced
03/05/2019
In Committee
03/05/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits. This bill prohibits health insurers and contracted entities that provide pharmacy benefits management services from receiving a price reduction or other remuneration from prescription drug manufacturers. The prohibition does not apply if (1) the price reduction is reflected at the point-of-sale; and (2) the other remuneration is a transparent, flat service fee that the manufacturer pays in relation to pharmacy benefits management services.

AI Summary

This bill amends Title XXVII of the Public Health Service Act to establish requirements for prescription drug benefits. The bill prohibits health insurers and pharmacy benefit managers (PBMs) from receiving price reductions or other remuneration from drug manufacturers, unless the price reduction is reflected at the point of sale to the enrollee and any other remuneration is a transparent, flat service fee paid by the manufacturer for PBM services. This provision aims to increase transparency and ensure that any savings from drug manufacturers are passed on to consumers at the point of purchase. The bill takes effect on January 1, 2020.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 03/05/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...